Investigation of molecular mechanisms underlying the role of ICAM-3 in the phagocytic clearance of apoptotic leukocytes

ICAM-3在凋亡白细胞吞噬清除中作用的分子机制研究

基本信息

  • 批准号:
    BB/E002080/1
  • 负责人:
  • 金额:
    $ 46.09万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2007
  • 资助国家:
    英国
  • 起止时间:
    2007 至 无数据
  • 项目状态:
    已结题

项目摘要

Damaged, infected, aged or unwanted cells in the body are induced to die via a process known as apoptosis. The final step in this process is the removal (phagocytosis) of dying cells by healthy neighbouring cells where the cell corpses are eaten and degraded in a safe and controlled environment. A range of molecules have been suggested to play a role in this process though the amount of information relating to molecules recognised on dying cells is limited. It has been suggested that changes at the surface of dying cells result in the exposure of signals or flags that identify the cell, to viable neighbours, as dying and ready for removal. Relatively little is currently known about the nature of such 'eat me' signals. Lipids at the cell surface are known to change during death with phosphatidylserine (PS) becoming exposed at the cell surface where in viable cells it is usually maintained within the inner leaflet of the cell membrane. Once exposed PS is recognised by receptors on viable cells and mediates dying cell clearance. A change in another molecule, ICAM-3 (Intercellular Adhesion Molecule-3) on the surface of dying leukocytes have been implicated in the recognition and removal of dying leukocytes by professional phagocytes, macrophages. ICAM-3 is a molecule found only on leukocytes and, when present on viable cells, is important in the initiation of immune responses by facilitating cell-cell interactions. To mediate this interaction ICAM-3 binds to counter-receptors including the integrin LFA-1 and the non-integrin DC-SIGN. Previous work has indicated that ICAM-3 on dying cells loses its ability to bind to its prototypic counter-receptor LFA-1. This apoptosis-related loss of function is associated with a gain of alternate function where ICAM-3 becomes able to bind to another, as yet unidentified, receptor - a function that is important in mediating the phagocytic clearance of apoptotic leukocytes. The removal of dying leukocytes is especially important for the resolution of inflammation and the control of immune responses. Failure to remove leukocytes at the appropriate time may lead to chronic inflammatory conditions and autoimmune disease. A better understanding of the molecules and processes involved within the clearance of dying leukocytes will be central to future strategies for improving human health and well-being. This project seeks to identify the changes that occur in ICAM-3 that underlie the loss of function (loss of LFA-1 binding) and the gain of function (ability to bind other receptor(s) and mediate clearance of dying leukocytes) that is reported during apoptosis. The change of function associated with ICAM-3 at the apoptotic cell surface may be due to changes in ICAM-3 location, partner molecules or structure (e.g. sugar content of ICAM-3) and any such changes may arise from or contribute to changes in the mobility of ICAM-3 as cells undergo apoptosis. Within this project we will identify and characterise changes in the structure and/or environment of ICAM-3 occurring during apoptosis and will relate these changes to dead cell clearance.
体内受损、感染、老化或不需要的细胞通过称为凋亡的过程被诱导死亡。这个过程的最后一步是通过健康的邻近细胞去除(吞噬)垂死细胞,在那里细胞尸体在安全和受控的环境中被吃掉和降解。一系列的分子已经被认为在这一过程中发挥作用,尽管与垂死细胞上识别的分子相关的信息量是有限的。有人认为,死亡细胞表面的变化导致将细胞识别为死亡并准备移除的信号或标志暴露于有活力的邻居。目前对这种“吃我”信号的性质知之甚少。已知细胞表面的脂质在死亡过程中发生变化,磷脂酰丝氨酸(PS)暴露在细胞表面,而在活细胞中,它通常保持在细胞膜的内小叶内。一旦暴露,PS被活细胞上的受体识别并介导死亡细胞清除。另一种分子ICAM-3(细胞间粘附分子-3)在垂死白细胞表面上的变化与专职吞噬细胞巨噬细胞识别和清除垂死白细胞有关。ICAM-3是仅在白细胞上发现的分子,并且当存在于活细胞上时,通过促进细胞-细胞相互作用在免疫应答的起始中是重要的。为了介导这种相互作用,ICAM-3与包括整联蛋白LFA-1和非整联蛋白DC-SIGN的反受体结合。先前的工作表明,垂死细胞上的ICAM-3失去了与其原型反受体LFA-1结合的能力。这种凋亡相关的功能丧失与替代功能的获得相关,其中ICAM-3能够结合另一种尚未鉴定的受体-一种在介导凋亡白细胞的吞噬清除中重要的功能。去除垂死的白细胞对于炎症的解决和免疫反应的控制特别重要。未能在适当的时间清除白细胞可能会导致慢性炎症和自身免疫性疾病。更好地了解死亡白细胞清除过程中涉及的分子和过程将是未来改善人类健康和福祉的战略的核心。该项目旨在确定ICAM-3中发生的变化,这些变化是细胞凋亡期间报告的功能丧失(LFA-1结合丧失)和功能获得(结合其他受体和介导死亡白细胞清除的能力)的基础。在凋亡细胞表面与ICAM-3相关的功能的变化可能是由于ICAM-3位置、配偶体分子或结构(例如ICAM-3的糖含量)的变化,并且任何这样的变化可能是由于细胞经历凋亡时ICAM-3的迁移率的变化引起的或有助于ICAM-3的迁移率的变化。在这个项目中,我们将识别和检测细胞凋亡过程中ICAM-3的结构和/或环境的变化,并将这些变化与死细胞清除联系起来。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Polymeric microspheres as protein transduction reagents.
  • DOI:
    10.1074/mcp.o113.034900
  • 发表时间:
    2014-06
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nagel D;Behrendt JM;Chimonides GF;Torr EE;Devitt A;Sutherland AJ;Hine AV
  • 通讯作者:
    Hine AV
Communicating with the dead: lipids, lipid mediators and extracellular vesicles.
  • DOI:
    10.1042/bst20160477
  • 发表时间:
    2018-05
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    A. Devitt;H. Griffiths;I. Milic
  • 通讯作者:
    A. Devitt;H. Griffiths;I. Milic
Porphyromonas gingivalis gingipains cause defective macrophage migration towards apoptotic cells and inhibit phagocytosis of primary apoptotic neutrophils.
  • DOI:
    10.1038/cddis.2016.481
  • 发表时间:
    2017-03-02
  • 期刊:
  • 影响因子:
    9
  • 作者:
    Castro SA;Collighan R;Lambert PA;Dias IH;Chauhan P;Bland CE;Milic I;Milward MR;Cooper PR;Devitt A
  • 通讯作者:
    Devitt A
Current understanding of the mechanisms for clearance of apoptotic cells-a fine balance.
  • DOI:
    10.4137/jcd.s11037
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hawkins LA;Devitt A
  • 通讯作者:
    Devitt A
Extracellular vesicles in the tumour microenvironment.
肿瘤微环境中的细胞外囊泡。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew Devitt其他文献

Klaus Ley (ed): Adhesion molecules: function and inhibition (Series: PIR—Progress in Inflammation Research)
  • DOI:
    10.1007/s10787-009-0024-x
  • 发表时间:
    2009-12-24
  • 期刊:
  • 影响因子:
    5.300
  • 作者:
    Andrew Devitt
  • 通讯作者:
    Andrew Devitt
Edinburgh Research Explorer Inhibitory effects of persistent apoptotic cells on monoclonal antibody production in vitro simple removal of non-viable cells improves antibody productivity by hybridoma cells in culture
爱丁堡研究探索者持续性凋亡细胞对体外单克隆抗体产生的抑制作用简单去除非活细胞可提高培养中杂交瘤细胞的抗体生产率
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Christopher D. Gregory;J. Pound;Andrew Devitt;Megan Wilson;Parthasarathi Ray;Ruth J Murray
  • 通讯作者:
    Ruth J Murray

Andrew Devitt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew Devitt', 18)}}的其他基金

A novel therapy for lymphoma & atherosclerosis - identification of commercialisation approaches
淋巴瘤的新疗法
  • 批准号:
    BB/S000011/1
  • 财政年份:
    2018
  • 资助金额:
    $ 46.09万
  • 项目类别:
    Research Grant
Active Extracellular Vesicles - defining a novel, extracellular metabolic compartment and its role in the control of inflammation.
活性细胞外囊泡 - 定义了一种新型的细胞外代谢区室及其在控制炎症中的作用。
  • 批准号:
    BB/S00324X/1
  • 财政年份:
    2018
  • 资助金额:
    $ 46.09万
  • 项目类别:
    Research Grant
Defining the molecular structure-function relationships of extracellular vesicles from dying cells.
定义死亡细胞的细胞外囊泡的分子结构-功能关系。
  • 批准号:
    BB/M006298/1
  • 财政年份:
    2015
  • 资助金额:
    $ 46.09万
  • 项目类别:
    Research Grant
Towards an in vitro system of predictive biomarkers of in vivo liposome efficacy
建立体内脂质体功效预测生物标志物的体外系统
  • 批准号:
    NC/L000261/1
  • 财政年份:
    2014
  • 资助金额:
    $ 46.09万
  • 项目类别:
    Research Grant

相似国自然基金

配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
  • 批准号:
    82370981
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 批准年份:
    2023
  • 资助金额:
    45.00 万元
  • 项目类别:
    面上项目
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
  • 批准号:
    82373145
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
  • 批准号:
    82304565
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
  • 批准号:
    82372328
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
Irisin通过整合素调控黄河鲤肌纤维发育的分子机制研究
  • 批准号:
    32303019
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
  • 批准号:
    82371704
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
上皮细胞黏着结构半桥粒在热激保护中的作用机制研究
  • 批准号:
    31900545
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigation of molecular mechanisms for overgrowth and aberrant hypermethylation using H19-ICR mutant mouse panel
使用 H19-ICR 突变小鼠组研究过度生长和异常高甲基化的分子机制
  • 批准号:
    23K05592
  • 财政年份:
    2023
  • 资助金额:
    $ 46.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of molecular mechanisms of LINE-1 regulation related to psychiatric disorders using animal models
使用动物模型研究与精神疾病相关的 LINE-1 调节的分子机制
  • 批准号:
    22KJ2505
  • 财政年份:
    2023
  • 资助金额:
    $ 46.09万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration
VEGFA 在利用胆管细胞驱动的肝再生中的作用的研究
  • 批准号:
    10631156
  • 财政年份:
    2022
  • 资助金额:
    $ 46.09万
  • 项目类别:
Investigation of the biophysical mechanisms and membrane determinants of respirovirus binding and fusion using artificial lipid membranes and isolated physiological membranes as targets
以人工脂质膜和分离的生理膜为靶标,研究呼吸道病毒结合和融合的生物物理机制和膜决定因素
  • 批准号:
    10513664
  • 财政年份:
    2022
  • 资助金额:
    $ 46.09万
  • 项目类别:
Investigation of the Cellular and Molecular Mechanisms of Thrombocyte Integrin Signaling
血小板整合素信号传导的细胞和分子机制研究
  • 批准号:
    10616738
  • 财政年份:
    2022
  • 资助金额:
    $ 46.09万
  • 项目类别:
Investigation of the cellular and molecular mechanisms that drive airway remodeling, a key pathological phenotype of chronic lung disease.
研究驱动气道重塑的细胞和分子机制,这是慢性肺病的关键病理表型。
  • 批准号:
    2748641
  • 财政年份:
    2022
  • 资助金额:
    $ 46.09万
  • 项目类别:
    Studentship
Molecular mechanisms of Slit-Robo signalling - investigation of SLIT3:Robo1 interactions during mammalian development
Slit-Robo 信号传导的分子机制 - 哺乳动物发育过程中 SLIT3:Robo1 相互作用的研究
  • 批准号:
    2775812
  • 财政年份:
    2022
  • 资助金额:
    $ 46.09万
  • 项目类别:
    Studentship
Investigation of the Cellular and Molecular Mechanisms of Thrombocyte Integrin Signaling
血小板整合素信号传导的细胞和分子机制研究
  • 批准号:
    10421216
  • 财政年份:
    2022
  • 资助金额:
    $ 46.09万
  • 项目类别:
The investigation of molecular mechanisms underlying refractory respiratory diseases using human lung derived organoids
利用人肺源性类器官研究难治性呼吸系统疾病的分子机制
  • 批准号:
    22K19560
  • 财政年份:
    2022
  • 资助金额:
    $ 46.09万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration
VEGFA 在利用胆管细胞驱动的肝再生中的作用的研究
  • 批准号:
    10501501
  • 财政年份:
    2022
  • 资助金额:
    $ 46.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了